249 related articles for article (PubMed ID: 12324249)
1. Ketolides: the future of the macrolides?
Nilius AM; Ma Z
Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249
[TBL] [Abstract][Full Text] [Related]
2. The ketolides: a critical review.
Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
[TBL] [Abstract][Full Text] [Related]
3. Ketolides in the treatment of respiratory infections.
Zhanel GG; Hoban DJ
Expert Opin Pharmacother; 2002 Mar; 3(3):277-97. PubMed ID: 11866679
[TBL] [Abstract][Full Text] [Related]
4. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
Zhanel GG; Hisanaga T; Nichol K; Wierzbowski A; Hoban DJ
Expert Opin Emerg Drugs; 2003 Nov; 8(2):297-321. PubMed ID: 14661991
[TBL] [Abstract][Full Text] [Related]
5. The emerging new generation of antibiotic: ketolides.
Zhong P; Shortridge V
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
[TBL] [Abstract][Full Text] [Related]
6. Recent developments on ketolides and macrolides.
Wu YJ; Su WG
Curr Med Chem; 2001 Dec; 8(14):1727-58. PubMed ID: 11562291
[TBL] [Abstract][Full Text] [Related]
7. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
Champney WS; Mentens N; Zurawick K
Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
[TBL] [Abstract][Full Text] [Related]
9. Ketolides-telithromycin, an example of a new class of antibacterial agents.
Bryskier A
Clin Microbiol Infect; 2000 Dec; 6(12):661-9. PubMed ID: 11284926
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Schmitz FJ; Schwarz S; Milatovic D; Verhoef J; Fluit AC
J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
[No Abstract] [Full Text] [Related]
11. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
Reinert RR
J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
[TBL] [Abstract][Full Text] [Related]
13. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae.
Jorgensen JH; Crawford SA; McElmeel ML; Whitney CG
Antimicrob Agents Chemother; 2004 Feb; 48(2):605-7. PubMed ID: 14742216
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
Dubois J; St -Pierre C
Diagn Microbiol Infect Dis; 2001; 40(1-2):35-40. PubMed ID: 11448561
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Giovanetti E; Montanari MP; Marchetti F; Varaldo PE
J Antimicrob Chemother; 2000 Dec; 46(6):905-8. PubMed ID: 11102408
[TBL] [Abstract][Full Text] [Related]
16. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin.
Leclercq R
J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():9-23. PubMed ID: 11566972
[TBL] [Abstract][Full Text] [Related]
17. [Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
Muller-Serieys C
Presse Med; 2000 Dec; 29(37):2061-4. PubMed ID: 11155736
[TBL] [Abstract][Full Text] [Related]
18. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Champney WS; Tober CL
Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
[TBL] [Abstract][Full Text] [Related]
19. Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.
Capobianco JO; Cao Z; Shortridge VD; Ma Z; Flamm RK; Zhong P
Antimicrob Agents Chemother; 2000 Jun; 44(6):1562-7. PubMed ID: 10817709
[TBL] [Abstract][Full Text] [Related]
20. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
